Antitargets and drug safety
Drug development Drug interactions Drugs sähkökirjat
Wiley-VCH
2015
EISBN 9783527673674
section 1. General concept for target-based safety assessment.
section 2. Hepatic side effects.
section 3. Cardiovascular side effects.
section 4. Kinase antitargets.
section 5. Examples of clinical translation.
section 2. Hepatic side effects.
section 3. Cardiovascular side effects.
section 4. Kinase antitargets.
section 5. Examples of clinical translation.
